1. Home
  2. CSIQ vs APMD Comparison

CSIQ vs APMD Comparison

Compare CSIQ & APMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canadian Solar Inc. (ON)

CSIQ

Canadian Solar Inc. (ON)

BUY

Current Price

$11.12

Market Cap

906.4M

Sector

Technology

ML Signal

BUY

Logo Apnimed Inc. Common Stock

APMD

Apnimed Inc. Common Stock

N/A

Current Price

$21.64

Market Cap

895.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSIQ
APMD
Founded
2001
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.4M
895.5M
IPO Year
2006
2026

Fundamental Metrics

Financial Performance
Metric
CSIQ
APMD
Price
$11.12
$21.64
Analyst Decision
Hold
Strong Buy
Analyst Count
12
4
Target Price
$17.85
★ $50.33
AVG Volume (30 Days)
★ 1.7M
461.3K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$136.17
Revenue Next Year
$26.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.34
$19.80
52 Week High
$34.59
$35.29

Technical Indicators

Market Signals
Indicator
CSIQ
APMD
Relative Strength Index (RSI) 38.48 40.17
Support Level N/A $19.80
Resistance Level $16.48 $30.50
Average True Range (ATR) 0.61 2.58
MACD 0.04 -0.37
Stochastic Oscillator 27.06 17.75

Price Performance

Historical Comparison
CSIQ
APMD

About CSIQ Canadian Solar Inc. (ON)

Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects. The company is organized in two segments: Manufacturing segment, comprising CS PowerTech, which focuses on manufacturing and sales of solar products, battery energy storage products, and other power technology products for the U.S. market and CSI Solar, which serves all other world-wide markets; and Recurrent Energy segment, which focuses on solar power and battery storage project development, asset sales, power services, and electricity revenue from its operating portfolio. It derives maximum revenue from Manufacturing segment.

About APMD Apnimed Inc. Common Stock

Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).

Share on Social Networks: